For many years, patients with prostate cancer that has spread outside the prostate but which has not spread to the lymph nodes or bones, have been offered radiotherapy to remove the cancer.
SPCG 15 is a randomised controlled trial which compares whether treatment with surgical removal of the prostate (radical prostatectomy) with possible subsequent radiotherapy has a better effect on the disease than the traditional radiotherapy together with medicinal castration treatment.
The trial is carried out in collaboration with the Department of Oncology at AUH where Consultant Lise Bentzen has clinical responsibility.
It is possible to participate at a number of urology/cancer departments in Denmark.
The study is carried out in collaboration with SPCG (Scandinavian Prostate Cancer Group) and approx. 1,200 patients will participate in the trial at a number of departments around Scandinavia.
